FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to haematology, cardiology, endocrinology, and can be used for correction of the blood microvesicle level in the patients with arterial hypertension and abdominal obesity. That is ensured by administration of Valsartan 80 mg once in the morning, Metformin 500 mg twice a day, and graduated physical activity. The length of treatment is at least 5 weeks.
EFFECT: invention provides normalisation of the blood microvesicle level in the case patients that allows considerably lowering hemocoagulation potential of blood, reducing risk of thrombotic complications.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND TYPE II DIABETES MELLITUS | 2009 |
|
RU2400209C1 |
METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, ABDOMINAL OBESITY AND TYPE II DIABETES MELLITUS | 2009 |
|
RU2400230C1 |
METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, ABDOMINAL OBESITY AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2400228C1 |
METHOD FOR CORRECTION OF BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND ABDOMINAL OBESITY | 2009 |
|
RU2400203C1 |
METHOD FOR DECREASING BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2393859C1 |
METHOD OF THROMBOPLASTIN FORMATION FOR PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2332205C1 |
METHOD OF BLOOD MICROVESICLE LEVEL NORMALISATION IN ARTERIAL HYPERTESION AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2398573C1 |
METHOD OF NORMALISATION OF MICROVESICLE LEVEL IN BLOOD IN CASE OF GLUCOSE TOLERANCE DISTURBANCE | 2009 |
|
RU2394572C1 |
METHOD OF NITROGEN OXIDE DELIVERY NORMALISATION IN VESSELS OF PATIENT SUFFERING FROM ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME | 2006 |
|
RU2330650C2 |
METHOD FOR ENHANCEMENT OF THROMBOCYTE ANTIOXIDANT PROOFNESS IN ARTERIAL HYPERTENSION CASES WITH METABOLIC SYNDROME | 2007 |
|
RU2331416C1 |
Authors
Dates
2010-07-10—Published
2009-04-17—Filed